|
Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- Suppliers list
|
|
| | Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- Basic information |
| Product Name: | Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- | | Synonyms: | Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- | | CAS: | 2378837-56-8 | | MF: | C78H119FN12O34 | | MW: | 1787.84 | | EINECS: | | | Product Categories: | | | Mol File: | 2378837-56-8.mol | ![Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- Structure](CAS/20210305/GIF/2378837-56-8.gif) |
| | Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- Chemical Properties |
| density | 1.48±0.1 g/cm3(Predicted) | | pka | 7.05±0.20(Predicted) |
| | Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- Usage And Synthesis |
| Uses | M-MoDE-A (2) is a bifunctional small molecule that mediates the degradation of extracellular proteins through the asialoglycoprotein receptor (ASGPR). | | References | [1] Caianiello DF, et al. Bifunctional small molecules that mediate the degradation of extracellular proteins. Nat Chem Biol. 2021 Sep;17(9):947-953. DOI:10.1038/s41589-021-00851-1 |
| | Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- Preparation Products And Raw materials |
|
|
Tag:Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]-(2378837-56-8)
Related Product Information
|